Phyxiom

Phyxiom is dedicated to bringing excellence in digital respiratory healthcare to millions. As a clinically proven digital platform, Phyxiom empowers clinicians to deliver more accurate diagnoses and precision treatments to patients managing uncontrolled asthma.

Born from over 12 years of clinical research at the Royal College of Surgeons in Ireland (RCSI), Phyxiom’s technology utilizes a family of patented algorithms and software platforms designed for the management of chronic respiratory diseases. Phyxiom is committed to replicating demonstrated outcomes for the 540 million patients globally affected by COPD or asthma. Evidence-based approaches have shown results of 30% cost savings through accurate diagnosis, a 20% reduction in steroid burden, and a 60% reduction in step-up treatment.

Phyxiom provides data-driven insights and trend analysis, giving clinicians a personalized perspective on patient care. Designed by clinicians for clinicians, the Phyxiom business model ensures seamless integration into existing systems and processes with minimal disruption. We invite the management of Phyxiom to create a customized and exclusive company showcase and product listing on our platform.